
Neupogen (filgrastim) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts
Description
Neupogen (filgrastim) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on neupogen (filgrastim) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for neupogen (filgrastim) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neupogen (filgrastim) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Drug Type: Biologic; Biosimilar
2) By Indication: Chemotherapy Induced Neutropenia; Chronic Neutropenia; Others
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Amgen Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on neupogen (filgrastim) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for neupogen (filgrastim) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neupogen (filgrastim) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Drug Type: Biologic; Biosimilar
2) By Indication: Chemotherapy Induced Neutropenia; Chronic Neutropenia; Others
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Amgen Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Neupogen (filgrastim) Market Characteristics
- 3. Neupogen (filgrastim) Market Biologic Drug Characteristics
- 3.1. Molecule Type
- 3.2. Route Of Administration (ROA)
- 3.3. Mechanism Of Action (MOA)
- 3.4. Safety And Efficacy
- 4. Neupogen (filgrastim) Market Trends And Strategies
- 5. Neupogen (filgrastim) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 6. Global Neupogen (filgrastim) Growth Analysis And Strategic Analysis Framework
- 6.1. Global Neupogen (filgrastim) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 6.2. Analysis Of End Use Industries
- 6.3. Global Neupogen (filgrastim) Market Growth Rate Analysis
- 6.4. Global Neupogen (filgrastim) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 6.5. Global Neupogen (filgrastim) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 6.6. Global Neupogen (filgrastim) Total Addressable Market (TAM)
- 7. Global Neupogen (filgrastim) Market Pricing Analysis & Forecasts
- 8. Neupogen (filgrastim) Market Segmentation
- 8.1. Global Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biologic
- Biosimilar
- 8.2. Global Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chemotherapy Induced Neutropenia
- Chronic Neutropenia
- Others
- 8.3. Global Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 9. Global Neupogen (filgrastim) Market Epidemiology Of Clinical Indications
- 9.1. Drug Side Effects
- 9.2. Incidence And Prevalence of Clinical Indications
- 10. Neupogen (filgrastim) Market Regional And Country Analysis
- 10.1. Global Neupogen (filgrastim) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. Global Neupogen (filgrastim) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Asia-Pacific Neupogen (filgrastim) Market
- 11.1. Asia-Pacific Neupogen (filgrastim) Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 11.2. Asia-Pacific Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Asia-Pacific Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Asia-Pacific Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. China Neupogen (filgrastim) Market
- 12.1. China Neupogen (filgrastim) Market Overview
- 12.2. China Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.3. China Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 12.4. China Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 13. India Neupogen (filgrastim) Market
- 13.1. India Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. India Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. India Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. Japan Neupogen (filgrastim) Market
- 14.1. Japan Neupogen (filgrastim) Market Overview
- 14.2. Japan Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. Japan Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. Japan Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Australia Neupogen (filgrastim) Market
- 15.1. Australia Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.2. Australia Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Australia Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. South Korea Neupogen (filgrastim) Market
- 16.1. South Korea Neupogen (filgrastim) Market Overview
- 16.2. South Korea Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. South Korea Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.4. South Korea Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Western Europe Neupogen (filgrastim) Market
- 17.1. Western Europe Neupogen (filgrastim) Market Overview
- 17.2. Western Europe Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Western Europe Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.4. Western Europe Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. UK Neupogen (filgrastim) Market
- 18.1. UK Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. UK Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. UK Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Germany Neupogen (filgrastim) Market
- 19.1. Germany Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Germany Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Germany Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. France Neupogen (filgrastim) Market
- 20.1. France Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. France Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. France Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Neupogen (filgrastim) Market
- 21.1. Eastern Europe Neupogen (filgrastim) Market Overview
- 21.2. Eastern Europe Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. North America Neupogen (filgrastim) Market
- 22.1. North America Neupogen (filgrastim) Market Overview
- 22.2. North America Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. North America Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.4. North America Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. USA Neupogen (filgrastim) Market
- 23.1. USA Neupogen (filgrastim) Market Overview
- 23.2. USA Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. USA Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. USA Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. Canada Neupogen (filgrastim) Market
- 24.1. Canada Neupogen (filgrastim) Market Overview
- 24.2. Canada Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. Canada Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. Canada Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. South America Neupogen (filgrastim) Market
- 25.1. South America Neupogen (filgrastim) Market Overview
- 25.2. South America Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. South America Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. South America Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. Middle East Neupogen (filgrastim) Market
- 26.1. Middle East Neupogen (filgrastim) Market Overview
- 26.2. Middle East Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. Middle East Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. Middle East Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Africa Neupogen (filgrastim) Market
- 27.1. Africa Neupogen (filgrastim) Market Overview
- 27.2. Africa Neupogen (filgrastim) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Africa Neupogen (filgrastim) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.4. Africa Neupogen (filgrastim) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Neupogen (filgrastim) Market Competitive Landscape And Company Profiles
- 28.1. Neupogen (filgrastim) Market Competitive Landscape
- 28.2. Neupogen (filgrastim) Market Company Profiles
- 28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 29. Global Neupogen (filgrastim) Market Pipeline Analysis
- 29.1. High Level Clinic Trail Information
- 30. Global Neupogen (filgrastim) Market Competitive Benchmarking And Dashboard
- 31. Key Mergers And Acquisitions In The Neupogen (filgrastim) Market
- 32. Recent Developments In The Neupogen (filgrastim) Market
- 33. Neupogen (filgrastim) Market High Potential Countries, Segments and Strategies
- 33.1 Neupogen (filgrastim) Market In 2029 - Countries Offering Most New Opportunities
- 33.2 Neupogen (filgrastim) Market In 2029 - Segments Offering Most New Opportunities
- 33.3 Neupogen (filgrastim) Market In 2029 - Growth Strategies
- 33.3.1 Market Trend Based Strategies
- 33.3.2 Competitor Strategies
- 34. Appendix
- 34.1. Abbreviations
- 34.2. Currencies
- 34.3. Historic And Forecast Inflation Rates
- 34.4. Research Inquiries
- 34.5. The Business Research Company
- 34.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.